company background image
BLFS

BioLife Solutions NasdaqCM:BLFS Stock Report

Last Price

US$23.67

Market Cap

US$1.0b

7D

6.1%

1Y

-44.1%

Updated

29 Sep, 2022

Data

Company Financials +
BLFS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends0/6

BLFS Stock Overview

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally.

BioLife Solutions, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BioLife Solutions
Historical stock prices
Current Share PriceUS$23.67
52 Week HighUS$58.80
52 Week LowUS$10.40
Beta1.9
1 Month Change0.77%
3 Month Change61.68%
1 Year Change-44.07%
3 Year Change46.38%
5 Year Change310.94%
Change since IPO-95.64%

Recent News & Updates

Sep 27
BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Shareholder Returns

BLFSUS Medical EquipmentUS Market
7D6.1%-1.1%-3.1%
1Y-44.1%-29.9%-21.5%

Return vs Industry: BLFS underperformed the US Medical Equipment industry which returned -30.1% over the past year.

Return vs Market: BLFS underperformed the US Market which returned -20.3% over the past year.

Price Volatility

Is BLFS's price volatile compared to industry and market?
BLFS volatility
BLFS Average Weekly Movement11.7%
Medical Equipment Industry Average Movement8.6%
Market Average Movement6.9%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.8%

Stable Share Price: BLFS is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: BLFS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1987435Mike Ricehttps://www.biolifesolutions.com

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials.

BioLife Solutions, Inc. Fundamentals Summary

How do BioLife Solutions's earnings and revenue compare to its market cap?
BLFS fundamental statistics
Market CapUS$1.01b
Earnings (TTM)-US$93.80m
Revenue (TTM)US$147.86m

6.8x

P/S Ratio

-10.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BLFS income statement (TTM)
RevenueUS$147.86m
Cost of RevenueUS$105.54m
Gross ProfitUS$42.31m
Other ExpensesUS$136.11m
Earnings-US$93.80m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.20
Gross Margin28.62%
Net Profit Margin-63.44%
Debt/Equity Ratio1.8%

How did BLFS perform over the long term?

See historical performance and comparison